Investigational Drug Information for Dapansutrile
✉ Email this page to a colleague
What is the development status for investigational drug Dapansutrile?
Dapansutrile is an investigational drug.
There have been 6 clinical trials for Dapansutrile.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2022.
The most common disease conditions in clinical trials are Syndrome, Infarction, and COVID-19. The leading clinical trial sponsors are Olatec Therapeutics LLC, Radboud University, and CTI Clinical Trial and Consulting Services.
Summary for Dapansutrile
US Patents | 0 |
International Patents | 26 |
US Patent Applications | 41 |
WIPO Patent Applications | 22 |
Japanese Patent Applications | 7 |
Clinical Trial Progress | Phase 1 (2022-12-01) |
Vendors | 38 |
Recent Clinical Trials for Dapansutrile
Title | Sponsor | Phase |
---|---|---|
Advanced Cardiovascular Imaging of the Systemic Effects of Inflammasome Activation | University of Virginia | Early Phase 1 |
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare | Olatec Therapeutics LLC | Phase 2/Phase 3 |
A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma | Merck Sharp & Dohme Corp. | Phase 1/Phase 2 |
Clinical Trial Summary for Dapansutrile
Top disease conditions for Dapansutrile
Top clinical trial sponsors for Dapansutrile
US Patents for Dapansutrile
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Dapansutrile
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Dapansutrile | Australia | AU2011344030 | 2030-12-15 | ⤷ Try a Trial |
Dapansutrile | Brazil | BR112013014583 | 2030-12-15 | ⤷ Try a Trial |
Dapansutrile | Canada | CA2820625 | 2030-12-15 | ⤷ Try a Trial |
Dapansutrile | China | CN103260613 | 2030-12-15 | ⤷ Try a Trial |
Dapansutrile | European Patent Office | EP2651407 | 2030-12-15 | ⤷ Try a Trial |
Dapansutrile | Japan | JP2014503533 | 2030-12-15 | ⤷ Try a Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |